Cash flow Haisco Pharmaceutical Group Co., Ltd.

Equities

002653

CNE100001BC7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2025-07-17			5-day change	1st Jan Change
48.06 ^CNY	+0.63%		+13.91%	+44.54%

Jul. 16	Haisco Pharmaceutical Receives US FDA Approval for Autoimmune Drug Trials	MT
Jul. 07	Haisco Pharmaceutical to Raise 1.37 Billion Yuan via Share Placement; Shares Slump 5%	MT

f7d2362677a1c8c3728340eb450fa.fM-b5GCrpSlf0kYWLZak1S5jQf87tOPpaPo5OjqHS5c.KP3TnSvSyG8quTdxW970ikMCeb5O3LeFAcxXWVfvf-5OnM3XIdqdbia9Bw

Published financial data: HAISCO PHARMACEUTICAL GROUP CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	3.33B	2.76B	3B	3.34B	3.69B
Other Revenues, Total	2.08M	8.46M	17.03M	19.94M	28.6M
Total Revenues	3.33B	2.77B	3.02B	3.36B	3.72B
Cost of Goods Sold, Total	1.07B	947M	925M	971M	1.06B
Gross Profit	2.26B	1.83B	2.09B	2.38B	2.66B
Selling General & Admin Expenses, Total	1.59B	1.33B	1.47B	1.52B	1.76B
Provision for Bad Debts	-243K	317K	905K	304K	1.68M
R&D Expenses	406M	434M	445M	517M	624M
Other Operating Expenses	42.69M	26.28M	35.82M	50.54M	8.6M
Other Operating Expenses, Total	2.03B	1.79B	1.95B	2.09B	2.4B
Operating Income	228M	37.6M	142M	295M	262M
Interest Expense, Total	-27.29M	-27.16M	-50.91M	-42.28M	-37.84M
Interest And Investment Income	302M	426M	235M	19.33M	141M
Net Interest Expenses	274M	399M	184M	-22.95M	103M
Currency Exchange Gains (Loss)	-2.43M	-169K	968K	-61.36K	758K
Other Non Operating Income (Expenses)	-7.1M	-1.1M	1.13M	-631K	-1.81M
EBT, Excl. Unusual Items	493M	436M	328M	271M	364M
Gain (Loss) On Sale Of Investments	-	-	-	-60.47M	77.08K
Gain (Loss) On Sale Of Assets	333K	-130K	-3.08K	-284K	31.1M
Asset Writedown	-18.79M	-618K	-842K	-13.02M	-83.19M
Other Unusual Items	215M	75.97M	39.3M	105M	151M
EBT, Incl. Unusual Items	689M	511M	367M	303M	463M
Income Tax Expense	88.25M	-6.84M	-25.03M	6.96M	-3.25M
Earnings From Continuing Operations	601M	518M	392M	296M	466M
Net Income to Company	601M	518M	392M	296M	466M
Minority Interest	35.42M	-173M	-115M	-451K	-70.74M
Net Income - (IS)	637M	345M	277M	295M	395M
Net Income to Common Incl Extra Items	637M	345M	277M	295M	395M
Net Income to Common Excl. Extra Items	637M	345M	277M	295M	395M
Per Share Items
Net EPS - Basic	0.59	0.32	0.26	0.27	0.35
Basic EPS - Continuing Operations	0.59	0.32	0.26	0.27	0.35
Basic Weighted Average Shares Outstanding	1.08B	1.08B	1.07B	1.09B	1.13B
Net EPS - Diluted	0.59	0.32	0.26	0.27	0.35
Diluted EPS - Continuing Operations	0.59	0.32	0.26	0.27	0.35
Diluted Weighted Average Shares Outstanding	1.08B	1.08B	1.07B	1.09B	1.13B
Normalized Basic EPS	0.32	0.09	0.08	0.15	0.14
Normalized Diluted EPS	0.32	0.09	0.08	0.15	0.14
Dividend Per Share	0.37	0.19	-	0.2	0.42
Payout Ratio	20.54	123.52	89.35	14.43	106.72
Supplemental Items
EBITDA	312M	133M	249M	505M	498M
EBITA	231M	42.5M	147M	396M	390M
EBIT	228M	37.6M	142M	295M	262M
EBITDAR	324M	141M	262M	512M	505M
Total Revenues (As Reported)	3.33B	2.77B	3.02B	3.36B	3.72B
Effective Tax Rate - (Ratio)	12.8	-1.34	-6.83	2.3	-0.7
Total Current Taxes	22.49M	-3.65M	16.22M	41.08M	25.97M
Total Deferred Taxes	65.76M	-3.19M	-41.25M	-34.12M	-29.22M
Normalized Net Income	344M	99.68M	90.46M	169M	157M
Interest Capitalized	7M	5.03M	1.1M	-	-
Interest on Long-Term Debt	-	-	-	346K	338K
Supplemental Operating Expense Items
Advertising Expense	6.74M	3.74M	2.49M	-	-
Marketing Expenses	1.01B	696M	764M	547M	658M
Selling and Marketing Expenses	1.26B	973M	1.13B	1.2B	1.36B
General and Administrative Expenses	316M	352M	328M	321M	401M
Research And Development Expense From Footnotes	413M	434M	448M	517M	624M
Net Rental Expense, Total	12.09M	8.22M	13.21M	7.64M	6.57M
Imputed Operating Lease Interest Expense	3.04M	1.82M	3.27M	1.32M	1.07M
Imputed Operating Lease Depreciation	9.05M	6.4M	9.94M	6.32M	5.5M
Maintenance & Repair Expenses, Total	-	1M	582K	391K	517K
Stock-Based Comp., R&D Exp. (Total)	168K	-	13M	6.38M	23.81M
Stock-Based Comp., G&A Exp. (Total)	9.13M	713K	-4.54M	1.62M	-
Stock-Based Comp., Other (Total)	9.04M	1.93M	-	204K	-
Total Stock-Based Compensation	18.34M	2.65M	8.46M	8.2M	23.81M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	454M	575M	775M	1.17B	1.06B
Short Term Investments	410M	-	-	-	-
Trading Asset Securities, Total	370M	-	-	160M	150M
Total Cash And Short Term Investments	1.23B	575M	775M	1.33B	1.21B
Accounts Receivable, Total	488M	570M	804M	884M	1.08B
Other Receivables	68.54M	78.5M	47.14M	46.79M	40.35M
Total Receivables	556M	648M	851M	931M	1.12B
Inventory	224M	260M	346M	281M	272M
Prepaid Expenses	-	-	-	-	22.55M
Other Current Assets, Total	81.38M	64.9M	81.32M	100M	113M
Total Current Assets	2.1B	1.55B	2.05B	2.64B	2.73B
Gross Property Plant And Equipment	1.62B	1.73B	1.76B	1.75B	1.76B
Accumulated Depreciation	-496M	-589M	-683M	-751M	-840M
Net Property Plant And Equipment	1.13B	1.14B	1.07B	996M	917M
Long-term Investments	399M	381M	422M	232M	147M
Other Intangibles, Total	600M	682M	708M	751M	1.28B
Deferred Tax Assets Long-Term	80.6M	83.57M	124M	148M	177M
Deferred Charges Long-Term	587M	822M	1.23B	1.43B	1.11B
Other Long-Term Assets, Total	108M	351M	430M	457M	444M
Total Assets	5B	5.01B	6.05B	6.65B	6.8B
Liabilities
Accounts Payable, Total	420M	301M	242M	209M	196M
Accrued Expenses, Total	320M	121M	137M	200M	190M
Short-term Borrowings	740M	452M	485M	99.98M	243M
Current Portion of Long-Term Debt	30M	326M	295M	834M	728M
Current Portion of Leases	-	8M	6.64M	7.41M	10.27M
Current Income Taxes Payable	47.73M	1.71M	16.1M	16.08M	5.49M
Unearned Revenue Current, Total	26.02M	28.44M	26.96M	14.61M	20.87M
Other Current Liabilities	132M	280M	280M	123M	174M
Total Current Liabilities	1.72B	1.52B	1.49B	1.5B	1.57B
Long-Term Debt	335M	452M	1.32B	855M	925M
Long-Term Leases	-	10.91M	4.52M	10.85M	4.14M
Unearned Revenue Non Current	87.14M	103M	98.52M	108M	95.06M
Deferred Tax Liability Non Current	1.33M	1.11M	776K	4.01M	3.77M
Other Non Current Liabilities	2.23M	-	-	379K	-
Total Liabilities	2.14B	2.09B	2.91B	2.48B	2.6B
Common Stock, Total	1.07B	1.08B	1.08B	1.11B	1.12B
Additional Paid In Capital	78.57M	97.62M	101M	853M	954M
Retained Earnings	1.79B	1.73B	1.81B	2.21B	2.18B
Treasury Stock	-24.76M	-38.31M	-24.44M	-9.15M	-80.94M
Comprehensive Income and Other	-13.3M	-26.82M	76.41M	11.86M	40.55M
Total Common Equity	2.9B	2.84B	3.04B	4.18B	4.21B
Minority Interest	-47.65M	78.27M	97.68M	-9.36M	-11.09M
Total Equity	2.85B	2.92B	3.13B	4.17B	4.2B
Total Liabilities And Equity	5B	5.01B	6.05B	6.65B	6.8B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.14B	1.14B	1.03B	1.05B	1.16B
ECS Total Common Shares Outstanding	1.14B	1.14B	1.03B	1.05B	1.16B
Book Value / Share	2.55	2.5	2.93	3.99	3.63
Tangible Book Value	2.3B	2.16B	2.33B	3.43B	2.94B
Tangible Book Value Per Share	2.03	1.9	2.25	3.27	2.53
Total Debt	1.1B	1.25B	2.11B	1.81B	1.91B
Net Debt	-129M	674M	1.34B	478M	704M
Debt Equivalent Oper. Leases	96.71M	65.77M	106M	61.12M	52.58M
Minority Interest, Total (Incl. Fin. Div)	-47.65M	78.27M	97.68M	-9.36M	-11.09M
Equity Method Investments, Total	268M	249M	185M	132M	105M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	105M	117M	172M	132M	140M
Inventories - Work In Process, Total	16.89M	36.95M	54.87M	63.26M	75.83M
Inventories - Finished Goods, Total	78.35M	65.2M	71.26M	59.61M	61.95M
Inventories - Others	27.95M	45.08M	56.87M	33.52M	-
Buildings, Total	685M	932M	922M	966M	931M
Machinery, Total	602M	677M	710M	749M	789M
Full Time Employees	3.77K	4.25K	4.73K	5.45K	5.34K
Accumulated Allowance for Doubtful Accounts (Supple)	6.1M	2.81M	3.72M	4.02M	5.73M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	637M	345M	277M	295M	395M
Depreciation & Amortization - CF	80.75M	97.15M	110M	115M	118M
Amortization of Goodwill and Intangible Assets - (CF)	2.52M	4.9M	5.03M	101M	128M
Depreciation & Amortization, Total	83.27M	102M	116M	217M	246M
Amortization of Deferred Charges, Total - (CF)	23.84M	54.24M	72.89M	5.79M	9.15M
(Gain) Loss From Sale Of Asset	-333K	130K	3.08K	284K	-31.1M
(Gain) Loss on Sale of Investments - (CF)	-296M	-421M	-228M	60.53M	-117M
Asset Writedown & Restructuring Costs	18.79M	618K	842K	12.97M	83.19M
Provision and Write-off of Bad Debts	-243K	317K	905K	304K	1.79M
Other Operating Activities, Total	2.96M	203M	167M	42.13M	110M
Change In Accounts Receivable	16.13M	-45.88M	-191M	-70.94M	-183M
Change In Inventories	-39.09M	-36.29M	-90.38M	66.19M	10.82M
Change In Accounts Payable	-473M	-265M	-4.41M	-352M	-82.55M
Change In Deferred Taxes	65.76M	-3.19M	-41.25M	-20.52M	-29.22M
Change in Other Net Operating Assets	168M	102M	14.82M	194M	29.75M
Cash from Operations	206M	35.8M	94.55M	450M	442M
Capital Expenditure	-602M	-703M	-700M	-391M	-441M
Sale of Property, Plant, and Equipment	1.79M	333K	365K	4.29M	31.42M
Cash Acquisitions	-38.95M	-	-	-	-
Divestitures	303M	180M	-	-	-
Investment in Marketable and Equity Securities, Total	-271M	782M	160M	340K	10.82M
Other Investing Activities, Total	47.82M	22.5M	304K	3.19M	96.81M
Cash from Investing	-559M	282M	-540M	-383M	-302M
Long-Term Debt Issued, Total	1.03B	932M	2B	898M	1.4B
Total Debt Issued	1.03B	932M	2B	898M	1.4B
Short Term Debt Repaid, Total	-	-2.26M	-	-	-
Long-Term Debt Repaid, Total	-1.01B	-817M	-1.15B	-1.21B	-1.31B
Total Debt Repaid	-1.01B	-819M	-1.15B	-1.21B	-1.31B
Issuance of Common Stock	5.64M	23.76M	-	794M	80.94M
Repurchase of Common Stock	-	-2.47M	-6.37M	-8.16M	-
Common Dividends Paid	-131M	-426M	-247M	-42.57M	-422M
Common & Preferred Stock Dividends Paid	-131M	-426M	-247M	-42.57M	-422M
Other Financing Activities, Total	15.2M	104M	26.71M	-108M	47.73K
Cash from Financing	-85.01M	-187M	624M	328M	-251M
Foreign Exchange Rate Adjustments	-1.79M	-6.77M	16.94M	-1.54M	4.87M
Net Change in Cash	-440M	124M	196M	393M	-105M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	373M	173M	197M	329M	414M
Levered Free Cash Flow	-910M	-893M	-782M	-175M	-210M
Unlevered Free Cash Flow	-893M	-876M	-750M	-149M	-186M
Change In Net Working Capital	559M	356M	335M	173M	188M
Net Debt Issued / Repaid	24.9M	113M	851M	-307M	90.38M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.85	0.47	1.6	2.9	2.44
Return on Total Capital	3.85	0.58	1.88	3.29	2.71
Return On Equity %	22.98	17.93	12.94	8.09	11.14
Return on Common Equity	24.14	12.01	9.43	8.18	9.42
Margin Analysis
Gross Profit Margin %	67.93	65.86	69.31	71.05	71.47
SG&A Margin	47.62	47.89	48.64	45.34	47.38
EBITDA Margin %	9.36	4.79	8.25	15.05	13.39
EBITA Margin %	6.93	1.53	4.86	11.81	10.47
EBIT Margin %	6.86	1.36	4.69	8.79	7.04
Income From Continuing Operations Margin %	18.06	18.66	12.99	8.81	12.53
Net Income Margin %	19.12	12.44	9.19	8.8	10.63
Net Avail. For Common Margin %	19.12	12.44	9.19	8.8	10.63
Normalized Net Income Margin	10.32	3.59	3	5.04	4.21
Levered Free Cash Flow Margin	-27.33	-32.22	-25.93	-5.21	-5.64
Unlevered Free Cash Flow Margin	-26.82	-31.6	-24.88	-4.43	-5
Asset Turnover
Asset Turnover	0.66	0.55	0.55	0.53	0.55
Fixed Assets Turnover	3.08	2.45	2.73	3.24	3.89
Receivables Turnover (Average Receivables)	6.48	5.23	4.37	3.95	3.77
Inventory Turnover (Average Inventory)	5.17	3.91	3.05	3.1	3.84
Short Term Liquidity
Current Ratio	1.22	1.02	1.38	1.76	1.74
Quick Ratio	1.04	0.81	1.09	1.5	1.48
Operating Cash Flow to Current Liabilities	0.12	0.02	0.06	0.3	0.28
Days Sales Outstanding (Average Receivables)	56.52	69.81	83.62	92.35	97.16
Days Outstanding Inventory (Average Inventory)	70.82	93.26	119.52	117.87	95.3
Average Days Payable Outstanding	171.95	133.93	98.14	90.88	70.43
Cash Conversion Cycle (Average Days)	-44.62	29.13	105	119.34	122.03
Long Term Solvency
Total Debt/Equity	38.7	42.78	67.38	43.32	45.46
Total Debt / Total Capital	27.9	29.96	40.26	30.22	31.25
LT Debt/Equity	11.73	15.87	42.28	20.75	22.11
Long-Term Debt / Total Capital	8.46	11.11	25.26	14.48	15.2
Total Liabilities / Total Assets	42.87	41.66	48.17	37.31	38.19
EBIT / Interest Expense	8.37	1.38	2.78	6.98	6.93
EBITDA / Interest Expense	11.42	5.14	5.05	12.1	13.41
(EBITDA - Capex) / Interest Expense	-10.63	-20.74	-8.7	2.85	1.77
Total Debt / EBITDA	3.55	8.95	8.21	3.53	3.76
Net Debt / EBITDA	-0.42	4.83	5.2	0.93	1.39
Total Debt / (EBITDA - Capex)	-3.81	-2.22	-4.77	14.97	28.55
Net Debt / (EBITDA - Capex)	0.45	-1.2	-3.02	3.96	10.52
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-15.44	-16.71	8.73	11.27	10.92
Gross Profit, 1 Yr. Growth %	-12.64	-19.25	14.43	14.06	11.57
EBITDA, 1 Yr. Growth %	-24.17	-60.11	35.23	59.08	-8.43
EBITA, 1 Yr. Growth %	-32.15	-83.15	57.02	84.76	-10.42
EBIT, 1 Yr. Growth %	-29.31	-83.53	276.51	108.39	-20.97
Earnings From Cont. Operations, 1 Yr. Growth %	26.61	-13.91	-24.33	-24.55	57.73
Net Income, 1 Yr. Growth %	28.9	-45.8	-19.72	6.51	34
Normalized Net Income, 1 Yr. Growth %	56.53	-70.99	-9.25	87	-18.41
Diluted EPS Before Extra, 1 Yr. Growth %	28.26	-45.76	-18.75	3.85	29.63
Accounts Receivable, 1 Yr. Growth %	-9.71	16.89	41.02	9.97	21.8
Inventory, 1 Yr. Growth %	18.31	16.1	33.1	-18.7	-3.44
Net Property, Plant and Equip., 1 Yr. Growth %	8.42	0.94	-5.53	-7.24	-7.93
Total Assets, 1 Yr. Growth %	-0.77	0.17	20.79	10.01	2.19
Tangible Book Value, 1 Yr. Growth %	12.28	-6.21	7.78	47.33	-14.35
Common Equity, 1 Yr. Growth %	22.39	-2.08	6.82	37.7	0.8
Cash From Operations, 1 Yr. Growth %	-73.02	-82.64	164.08	375.51	-1.68
Capital Expenditures, 1 Yr. Growth %	3.27	16.82	-0.4	-44.16	12.7
Levered Free Cash Flow, 1 Yr. Growth %	1.86K	0.47	-12.68	-77.63	37.71
Unlevered Free Cash Flow, 1 Yr. Growth %	2.74K	0.49	-14.61	-80.2	47.84
Dividend Per Share, 1 Yr. Growth %	304.35	-50.22	-	-	107.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.43	-16.07	-4.84	9.99	11.09
Gross Profit, 2 Yr. CAGR %	8.19	-16.01	-3.88	14.24	12.81
EBITDA, 2 Yr. CAGR %	15.07	-43.15	-13.57	65.67	25.32
EBITA, 2 Yr. CAGR %	15.52	-64.66	-23.76	106.04	34.76
EBIT, 2 Yr. CAGR %	18.3	-65.88	-21.26	180.11	36.05
Earnings From Cont. Operations, 2 Yr. CAGR %	37.6	4.4	-19.29	-24.43	9.09
Net Income, 2 Yr. CAGR %	38.22	-16.41	-34.04	-7.52	19.47
Normalized Net Income, 2 Yr. CAGR %	65.85	-32.61	-48.69	30.27	31.6
Diluted EPS Before Extra, 2 Yr. CAGR %	37.96	-16.59	-33.62	-8.14	16.02
Accounts Receivable, 2 Yr. CAGR %	-19.33	2.73	28.39	24.53	15.73
Inventory, 2 Yr. CAGR %	22.71	17.2	24.31	4.02	-11.4
Net Property, Plant and Equip., 2 Yr. CAGR %	14.49	4.61	-2.35	-6.39	-7.58
Total Assets, 2 Yr. CAGR %	6.98	-0.3	10	15.29	6.03
Tangible Book Value, 2 Yr. CAGR %	14.25	2.62	0.54	26.01	12.34
Common Equity, 2 Yr. CAGR %	19.67	9.47	2.27	21.28	17.81
Cash From Operations, 2 Yr. CAGR %	-33.95	-78.36	-32.29	254.37	116.23
Capital Expenditures, 2 Yr. CAGR %	30.75	9.84	7.87	-25.42	-20.67
Levered Free Cash Flow, 2 Yr. CAGR %	179.17	338.4	-6.23	-55.8	-48.21
Unlevered Free Cash Flow, 2 Yr. CAGR %	192.47	428.41	-7.26	-58.88	-50.19
Dividend Per Share, 2 Yr. CAGR %	39.92	41.88	-	3.92	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.5	-6.81	-8.51	0.25	10.3
Gross Profit, 3 Yr. CAGR %	23.62	-1.87	-6.89	1.76	13.35
EBITDA, 3 Yr. CAGR %	21.87	-17.36	-15.41	14.88	39.41
EBITA, 3 Yr. CAGR %	25.71	-37.37	-24.47	16.27	60.99
EBIT, 3 Yr. CAGR %	27.95	-38.69	-24.04	8.91	91.01
Earnings From Cont. Operations, 3 Yr. CAGR %	37.93	17.69	-6.22	-21.08	-3.43
Net Income, 3 Yr. CAGR %	38.9	1.17	-17.53	-22.61	4.65
Normalized Net Income, 3 Yr. CAGR %	50.32	-7.25	-25.58	-21.04	16.27
Diluted EPS Before Extra, 3 Yr. CAGR %	38.93	1.06	-17.32	-22.94	3.03
Accounts Receivable, 3 Yr. CAGR %	2.84	-8.72	14.17	21.93	23.62
Inventory, 3 Yr. CAGR %	15.27	20.47	22.28	7.9	1.47
Net Property, Plant and Equip., 3 Yr. CAGR %	13.61	9.78	1.11	-4.01	-6.91
Total Assets, 3 Yr. CAGR %	6.74	4.66	6.29	10.01	10.75
Tangible Book Value, 3 Yr. CAGR %	8.88	6.98	4.31	14.2	10.79
Common Equity, 3 Yr. CAGR %	13.49	11.93	8.58	12.93	14.03
Cash From Operations, 3 Yr. CAGR %	-19.26	-57.69	-50.17	29.67	131.13
Capital Expenditures, 3 Yr. CAGR %	15.23	25.93	6.31	-13.38	-14.42
Levered Free Cash Flow, 3 Yr. CAGR %	6.92	97.05	156.22	-41.84	-38.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	5.5	103.25	188.03	-44.57	-40.39
Dividend Per Share, 3 Yr. CAGR %	9.93	-0.85	-	-18.69	30.86
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	22.39	14.08	10.19	-0.42	-1.12
Gross Profit, 5 Yr. CAGR %	22.77	11.41	11.79	4.29	0.54
EBITDA, 5 Yr. CAGR %	-4.44	-16.26	7.64	16.49	3.93
EBITA, 5 Yr. CAGR %	-7.55	-30.75	4.76	18.04	2.74
EBIT, 5 Yr. CAGR %	-7.55	-32.12	5.37	12.57	-4.1
Earnings From Cont. Operations, 5 Yr. CAGR %	10.07	3.48	11.32	-1.42	-0.37
Net Income, 5 Yr. CAGR %	11.33	-4.86	3.12	-2.4	-4.35
Normalized Net Income, 5 Yr. CAGR %	6.26	-14.15	-2.21	6.25	-6.52
Diluted EPS Before Extra, 5 Yr. CAGR %	11.01	-4.84	3.4	-2.73	-5.32
Accounts Receivable, 5 Yr. CAGR %	61.77	22.51	12.38	3.36	14.8
Inventory, 5 Yr. CAGR %	23.23	16.5	18.8	13.6	7.49
Net Property, Plant and Equip., 5 Yr. CAGR %	11.2	9.97	6.93	3	-2.46
Total Assets, 5 Yr. CAGR %	9.13	5.98	8.03	8.79	6.19
Tangible Book Value, 5 Yr. CAGR %	3.12	0.81	5.46	14.22	7.45
Common Equity, 5 Yr. CAGR %	6.12	4.76	8.86	15.58	12.18
Cash From Operations, 5 Yr. CAGR %	-14.18	-38.57	-24.75	-0.99	-10.37
Capital Expenditures, 5 Yr. CAGR %	16.23	27.55	12.23	2.13	-5.43
Levered Free Cash Flow, 5 Yr. CAGR %	6.31	-0.14	0.98	8.42	35.17
Unlevered Free Cash Flow, 5 Yr. CAGR %	5.62	-0.26	-0.27	7.31	42.75
Dividend Per Share, 5 Yr. CAGR %	8.27	-16.64	-	1.03	35.16